A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes

远程提供情景未来思维干预以改善 2 型糖尿病的管理

基本信息

项目摘要

PROJECT SUMMARY Successful management of type 2 diabetes requires adhering to physician-recommended medication, dietary, and exercise regimens. Most of these adherence-related behaviors provide little to no short-term benefit and rather may be aversive (e.g., caloric restriction and physical exertion). However, treatment adherence provides critical health benefits in the future, allowing patients to halt or reverse disease progression and avoid diabetes-related complications (e.g., renal disease or diabetic retinopathy). Thus, successful management of type 2 diabetes requires one's present behavior to be guided by future outcomes. Unfortunately, accumulating evidence indicates that individuals with type 2 diabetes and those at risk for this disorder rapidly devalue the future (a phenomenon known as delay discounting), which past and present data suggest contributes to treatment nonadherence. Thus, interventions shown to increase valuation of the future are likely to improve adherence. One such intervention is episodic future thinking (EFT), a form of prospection in which participants vividly imagine events that might occur in their future. Recent and ongoing work indicate that EFT, which activates neural systems associated with both planning and prospection, improves valuation of the future and reduces a wide range of maladaptive health behaviors (e.g., dietary intake in overweight/obese populations and cigarette smoking in smokers). The overall goal of this project is to use a remotely delivered EFT intervention to improve treatment adherence and adherence-related outcomes in type 2 diabetes. In Specific Aim 1, participants with poorly controlled type 2 diabetes (defined as hemoglobin A1C ≥8%) will engage in either EFT or a control thinking condition in the natural environment during a four-week trial. Outcome measures will be assessed at baseline, as well as 4-week and 6-month follow-up laboratory visits, and will include medication adherence, dietary intake, body mass index, glycemic control, blood pressure, and delay discounting. During the trial, we will also remotely assess physical activity, medication adherence, dietary intake, and delay discounting. In Specific Aim 2, we will examine acceptability of the remotely delivered EFT intervention. For an intervention to be effective in clinical settings, it should be easy to use and its helpfulness should be clear to patients. Thus, participants will rate the EFT or control conditions along several dimensions of acceptability, including ease of use, usefulness, and helpfulness. Ratings will be obtained separately for components of both the intervention and measurement to isolate acceptability of the intervention itself. High intervention ratings would suggest that EFT may be implemented with high treatment fidelity in clinical settings and is more likely to be disseminated among treatment providers and adopted by patients.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffrey Scott Stein其他文献

Jeffrey Scott Stein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffrey Scott Stein', 18)}}的其他基金

Episodic Future Thinking to Improve Management of Type 2 Diabetes in Rural and Urban Patients: Remote Delivery and Outcomes Assessment to Increase Reach and Dissemination
改善农村和城市患者 2 型糖尿病管理的情景未来思考:远程交付和结果评估以扩大覆盖范围和传播
  • 批准号:
    10280621
  • 财政年份:
    2021
  • 资助金额:
    $ 21.51万
  • 项目类别:
Episodic Future Thinking to Improve Management of Type 2 Diabetes in Rural and Urban Patients: Remote Delivery and Outcomes Assessment to Increase Reach and Dissemination
改善农村和城市患者 2 型糖尿病管理的情景未来思考:远程交付和结果评估以扩大覆盖范围和传播
  • 批准号:
    10683258
  • 财政年份:
    2021
  • 资助金额:
    $ 21.51万
  • 项目类别:
Episodic Future Thinking to Improve Management of Type 2 Diabetes in Rural and Urban Patients: Remote Delivery and Outcomes Assessment to Increase Reach and Dissemination
改善农村和城市患者 2 型糖尿病管理的情景未来思考:远程交付和结果评估以扩大覆盖范围和传播
  • 批准号:
    10488205
  • 财政年份:
    2021
  • 资助金额:
    $ 21.51万
  • 项目类别:
Episodic Future Thinking to Improve Management of Type 2 Diabetes in Rural and Urban Patients: Remote Delivery and Outcomes Assessment to Increase Reach and Dissemination
改善农村和城市患者 2 型糖尿病管理的情景未来思考:远程交付和结果评估以扩大覆盖范围和传播
  • 批准号:
    10667183
  • 财政年份:
    2021
  • 资助金额:
    $ 21.51万
  • 项目类别:

相似海外基金

A mixed-methods investigation of the influence of poor sleep on adherence to adjuvant hormonal therapy in breast cancer survivors
睡眠不良对乳腺癌幸存者辅助激素治疗依从性影响的混合方法研究
  • 批准号:
    2607728
  • 财政年份:
    2021
  • 资助金额:
    $ 21.51万
  • 项目类别:
    Studentship
Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors
基于社区药房的计划的试点研究,以提高乳腺癌幸存者对辅助内分泌治疗的依从性
  • 批准号:
    402816
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
    Operating Grants
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors
基于移动 TXT 的干预措施可提高 BCa 幸存者对辅助激素治疗和症状管理的依从性
  • 批准号:
    10310855
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors
基于移动 TXT 的干预措施可提高 BCa 幸存者对辅助激素治疗和症状管理的依从性
  • 批准号:
    10414810
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors
基于移动 TXT 的干预措施可提高 BCa 幸存者对辅助激素治疗和症状管理的依从性
  • 批准号:
    10524099
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors
基于移动 TXT 的干预措施可提高 BCa 幸存者对辅助激素治疗和症状管理的依从性
  • 批准号:
    10177879
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors
基于移动 TXT 的干预措施可提高 BCa 幸存者对辅助激素治疗和症状管理的依从性
  • 批准号:
    10657455
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
Improving Adherence to Adjuvant Hormonal Therapy among Disadvantaged Breast Cancer Survivors
提高弱势乳腺癌幸存者对辅助激素治疗的依从性
  • 批准号:
    9767687
  • 财政年份:
    2019
  • 资助金额:
    $ 21.51万
  • 项目类别:
Communication App to Manage Symptoms and Improve Adjuvant Endocrine Therapy Adherence
用于管理症状和提高辅助内分泌治疗依从性的通信应用程序
  • 批准号:
    9369578
  • 财政年份:
    2017
  • 资助金额:
    $ 21.51万
  • 项目类别:
Communication App to Manage Symptoms and Improve Adjuvant Endocrine Therapy Adherence
用于管理症状和提高辅助内分泌治疗依从性的通信应用程序
  • 批准号:
    9768995
  • 财政年份:
    2017
  • 资助金额:
    $ 21.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了